Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know

Adaptive Biotechnologies (ADPT) closed the last trading session at $5.58, gaining 20.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.33 indicates a 31.4% upside potential.The average comprises six short-term price targets ranging from a low of $5 to a high of $10, with a standard deviation of $1.63. While the lowest estimate indicates a decline of 10.4% from the current price ...